Vertero Therapeutics, Inc. マイクロバイオーム腸脳連関
2 known investors
Vertero is a biotech company developing oral therapeutics that target peripheral drivers of neurodegenerative diseases such as Parkinson's. Its lead candidate, VT-5006, targets a validated target in the gut linked to the protein aggregation and inflammation associated with Parkinson's disease.